tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals Stock Analysis & Ratings

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ACAD FAQ

What was ACADIA Pharmaceuticals’s price range in the past 12 months?
ACADIA Pharmaceuticals lowest stock price was $12.24 and its highest was $28.05 in the past 12 months.
    What is ACADIA Pharmaceuticals’s market cap?
    Currently, no data Available
    What is ACADIA Pharmaceuticals’s price target?
    The average price target for ACADIA Pharmaceuticals is $19.57. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $26.00 ,the lowest forecast is $10.00. The average price target represents 17.75% Increase from the current price of $16.62.
      What do analysts say about ACADIA Pharmaceuticals?
      ACADIA Pharmaceuticals’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
        When is ACADIA Pharmaceuticals’s upcoming earnings report date?
        ACADIA Pharmaceuticals’s upcoming earnings report date is Nov 07, 2022 which is in 90 days.
          How were ACADIA Pharmaceuticals’s earnings last quarter?
          ACADIA Pharmaceuticals released its earnings results on Aug 08, 2022. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.248 by $0.038.
            Is ACADIA Pharmaceuticals overvalued?
            According to Wall Street analysts ACADIA Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does ACADIA Pharmaceuticals pay dividends?
              ACADIA Pharmaceuticals does not currently pay dividends.
              What is ACADIA Pharmaceuticals’s EPS estimate?
              ACADIA Pharmaceuticals’s EPS estimate is -$0.2.
                How many shares outstanding does ACADIA Pharmaceuticals have?
                ACADIA Pharmaceuticals has 161,429,370 shares outstanding.
                  What happened to ACADIA Pharmaceuticals’s price movement after its last earnings report?
                  ACADIA Pharmaceuticals reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.248. Following the earnings report the stock price went same N/A.
                    Which hedge fund is a major shareholder of ACADIA Pharmaceuticals?
                    Among the largest hedge funds holding ACADIA Pharmaceuticals’s share is Fairmount Funds Management Llc. It holds ACADIA Pharmaceuticals’s shares valued at 28M.

                      ---

                      ACADIA Pharmaceuticals Stock Analysis

                      The ACADIA Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      ACADIA Pharmaceuticals

                      ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      AbbVie
                      Amgen
                      Gilead Sciences
                      Moderna
                      Vertex Pharmaceuticals

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis